Why the study?
Depression can be a prodromal symptom of brain diseases, but this association remains poorly studied regarding cerebrovascular diseases.
Is depression associated with cerebrovascular diseases?
Is depression associated with cerebrovascular diseases?
Depression appears to be associated with cerebrovascular changes, highlighting the need to evaluate depressive disorders in patients with brain diseases.
Depression warrants cerebrovascular evaluation in older adults; leaves open causal links between structural brain changes and mood.
Depression can be a prodromal symptom of brain diseases, but this association remains poorly studied with regards to cerebrovascular diseases. This review aimed to analyze the relationship between cerebrovascular diseases and depression. The objectives of the current review were: 1 – to assess the relationship between structural changes in the brain and depression; 2 – to evaluate the connection between cognitive performance and cerebrovascular impairment; 3 – to assess the relationship between biological correlates of brain diseases and depression. A search of the PubMed database was conducted focusing on papers published until 4th March 2021. The following terms were used: brain diseases and depression/pathology. A depressive disorder might have a relationship with structural or biological changes in the brain. However, this does not give the precise conclusion that depression definitely appears while a person has the cerebrovascular disease. Nevertheless, people with cerebrovascular diseases were observed to have high depression scale scores, while depression and cerebrovascular diseases had inflammation, cognitive change, or dopamine and serotonin changes in common. This is an overall limit concerning the definition of depression and cerebrovascular diseases. So, in this review, we observed all the possible connections between depression and brain diseases. Depression seems to be associated with cerebrovascular changes in people. They might have structural changes in the hippocampus, white matter, cortex, and other parts, as well as inflammatory processes, neuromediators changes, and cognitive decline. Thus, it is essential to evaluate depressive disorders in people with brain diseases as precisely as possible.
No takes yet. Share an insight, caveat, or question.
Abykayev et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: